Concorso OSS Azienda Universitaria Federico II: gli Idonei in graduatoria chiedono l'assunzione. - AssoCareNews.it - Quotidiano Sanitario Nazionale
miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase | British Journal of Cancer